The objective of this study was to determine the cost-effectiveness of intra-arterial treatment within the @ - to @-hour window after intravenous tissue-type plasminogen activator within @ - to @-hour compared with intravenous tissue-type plasminogen activator alone , in the US setting and from a social perspective .